📰 Curated Industry Article
This is a summary of a full article from a trusted insurance publication. Click “Read Full Article” below to read the complete story.
A 12.7 million-patient analysis finds less effective GLP-1 users persisted on therapy at nearly the same rate as effective users, with no measurable benefit
💡 What This Means For You
[legacy_dynamic_insight]
LEGACY LIFE INSURANCE GROUP
Ready to Protect Your Family?
No pressure. No jargon. Just honest answers from advisors who genuinely care about your family’s future.
📰 This article is sourced from a trusted insurance industry publication. Legacy Life Insurance Group shares this for informational purposes only. Always consult a licensed advisor for personalized guidance.